Ping AN Healthcare and Technology Co Ltd

Ping An Healthcare and Technology Co Ltd maintains a strong liquidity position, with a current ratio of 2.7 and cash and equivalents of CNY 1.23 billion. The company's debt-to-equity ratio is 0.01, indicating a conservative capital structure with minimal leverage. Despite a negative free cash flow of CNY -3.49 billion, the company's operating cash flow remains positive at CNY 450.95 million, suggesting operational cash generation is sufficient to support short-term obligations. Profitability metrics show a return on equity (ROE) of 3.83% and a return on assets (ROA) of 2.87%. These figures are below the industry median for healthcare facilities and services, which typically report ROE and ROA in the 5-7% range. The company's net income of CNY 379.51 million and operating income of CNY 271.64 million reflect modest profitability, with gross profit of CNY 1.77 billion contributing to a gross margin of 32.4%. The company's revenue is concentrated in a few key segments, with disclosed operations in healthcare facilities, biotechnology, and technology services. Geographic exposure is primarily within China, with no material international revenue disclosed in the latest financials. This concentration may expose the company to regulatory and macroeconomic risks specific to the Chinese market. Looking ahead, the company is expected to maintain a stable revenue trajectory, with no significant growth or contraction projected in the current or next fiscal year. Analysts have assigned a mean price target of CNY 15.46, with a median of CNY 14.50, suggesting a neutral outlook. The company's capital expenditure of CNY -39.92 million indicates minimal investment in new infrastructure, which may limit long-term growth potential. Risk factors include low liquidity and dilution risk, with no immediate filing-based flags detected. The company's low debt levels and strong equity position reduce credit risk, but the negative free cash flow could become a concern if sustained. No dilution pressure is currently expected, with shares outstanding remaining unchanged between basic and diluted counts. Recent events include the release of the latest financial report, which disclosed the company's revenue, profitability, and capital structure. No material regulatory or legal filings were reported in the last quarter, and no significant changes in management or strategy were disclosed.